First Tracks Biotherapeutics, Inc. (TRAX)

39.04 +0.57 (+1.48%) USD  |  NASDAQ  |  Sep 16, 16:00
39.15 +0.11 (+0.28%) After-Hours: 20:00
More

First Tracks Biotherapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for TRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Total Expenses (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
June 30, 2025 --
March 31, 2025 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Forte Biosciences, Inc. Upgrade
Immunovant, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Agenus, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade